Studies have shown that AKT activation is closely related to elevated EMT in many cancers, such as colorectal cancer (Ma et al., 2020), cervical cancer (Xu et al., 2021), and bladder cancer (Chi et al., 2022). This evidence concerns the gene AKT1 and urinary bladder cancer.